Gregory A. Korbel
2021
In 2021, Gregory A. Korbel earned a total compensation of $667.2K as Former Chief Operating Officer at Aprea Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $69,000 |
|---|---|
| Option Awards | $180,429 |
| Salary | $271,859 |
| Stock Awards | $145,950 |
| Total | $667,238 |
Korbel received $271.9K in salary, accounting for 41% of the total pay in 2021.
Korbel also received $69K in non-equity incentive plan, $180.4K in option awards and $146K in stock awards.
Rankings
In 2021, Gregory A. Korbel's compensation ranked 10,043rd out of 12,415 executives tracked by ExecPay. In other words, Korbel earned more than 19.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,043 out of 12,415 | 19th |
Division Manufacturing | 4,446 out of 5,505 | 19th |
Major group Chemicals And Allied Products | 1,980 out of 2,375 | 17th |
Industry group Drugs | 1,759 out of 2,096 | 16th |
Industry Pharmaceutical Preparations | 1,311 out of 1,546 | 15th |
Source: SEC filing on July 11, 2023.
Korbel's colleagues
We found three more compensation records of executives who worked with Gregory A. Korbel at Aprea Therapeutics in 2021.